Dr.Reddys Laboratories reported INR26.1B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Bharat Petroleum INR 8.66B 88.2M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 15.8B 660M Sep/2025